Summary

The research team projects that the Sustained-release Medicine market size will grow from XXX in 2024 to XXX by 2029, at an estimated CAGR of XX. The base year considered for the study is 2023, and the market size is projected from 2024 to 2029.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:
Sanofi
Novartis
Bayer
Johnson & Johnson
Takeda
AstraZeneca
AbbVie
Pfizer
Collegium Pharmaceutical
Inc
Endo Pharmaceuticals
Shanghai Shyndec Pharmaceutical
Zhuhai Rundu Pharmaceutical
China Res Double-Crane

By Type
Original Ground Medicine
Generic Medicine

By Application
Hospital
Drugstore
Other

By Regions/Countries:
North America
United States
Canada
Mexico

East Asia
China
Japan
South Korea

Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland

South Asia
India
Pakistan
Bangladesh

Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar

Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman

Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo

Oceania
Australia
New Zealand

South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador

Rest of the World
Kazakhstan

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Sustained-release Medicine 2018-2023, and development forecast 2024-2029 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2018-2023 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2024-2029. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Sustained-release Medicine Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Sustained-release Medicine Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Sustained-release Medicine market in 2023. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sustained-release Medicine Revenue
1.4 Market Analysis by Type
1.4.1 Global Sustained-release Medicine Market Size Growth Rate by Type: 2024 VS 2029
1.4.2 Original Ground Medicine
1.4.3 Generic Medicine
1.5 Market by Application
1.5.1 Global Sustained-release Medicine Market Share by Application: 2024-2029
1.5.2 Hospital
1.5.3 Drugstore
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Sustained-release Medicine Market
1.8.1 Global Sustained-release Medicine Market Status and Outlook (2018-2029)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
1.9 Global Market Growth Prospects
1.9.1 Global Sustained-release Medicine Revenue Estimates and Forecasts (2018-2029)
1.9.2 Global Sustained-release Medicine Production Capacity Estimates and Forecasts (2018-2029)
1.9.3 Global Sustained-release Medicine Production Estimates and Forecasts (2018-2029)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material
2.2 Manufacturing Cost Structure Analysis of Sustained-release Medicine
2.3 Manufacturing Process Analysis of Sustained-release Medicine
2.4 Industry Chain Structure of Sustained-release Medicine
3 Development and Manufacturing Plants Analysis of Sustained-release Medicine
3.1 Top Manufacturers Headquarters, Rank by Sustained-release Medicine Production
3.2 Global Sustained-release Medicine Manufacturing Plants Distribution and Commercial Production Date
4 Market Competition by Manufacturers
4.1 Global Sustained-release Medicine Production Capacity Market Share by Manufacturers (2018-2023)
4.2 Global Sustained-release Medicine Revenue Market Share by Manufacturers (2018-2023)
4.3 Global Sustained-release Medicine Average Price by Manufacturers (2018-2023)
4.4 Manufacturers Sustained-release Medicine Production Sites, Area Served, Product Type
5 Sustained-release Medicine Regional Market Analysis
5.1 Sustained-release Medicine Production by Regions
5.1.1 Global Sustained-release Medicine Production by Regions (2018-2023)
5.1.2 Global Sustained-release Medicine Revenue by Regions
5.2 Sustained-release Medicine Consumption by Regions
5.3 North America Sustained-release Medicine Market Analysis
5.3.1 North America Sustained-release Medicine Production
5.3.2 North America Sustained-release Medicine Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Sustained-release Medicine Import and Export
5.4 East Asia Sustained-release Medicine Market Analysis
5.4.1 East Asia Sustained-release Medicine Production
5.4.2 East Asia Sustained-release Medicine Revenue
5.4.3 Key Manufacturers in East Asia
5.4.4 East Asia Sustained-release Medicine Import & Export
5.5 Europe Sustained-release Medicine Market Analysis
5.5.1 Europe Sustained-release Medicine Production
5.5.2 Europe Sustained-release Medicine Revenue
5.5.3 Key Manufacturers in Europe
5.5.4 Europe Sustained-release Medicine Import & Export
5.6 South Asia Sustained-release Medicine Market Analysis
5.6.1 South Asia Sustained-release Medicine Production
5.6.2 South Asia Sustained-release Medicine Revenue
5.6.3 Key Manufacturers in South Asia
5.6.4 South Asia Sustained-release Medicine Import & Export
5.7 Southeast Asia Sustained-release Medicine Market Analysis
5.7.1 Southeast Asia Sustained-release Medicine Production
5.7.2 Southeast Asia Sustained-release Medicine Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Sustained-release Medicine Import & Export
5.8 Middle East Sustained-release Medicine Market Analysis
5.8.1 Middle East Sustained-release Medicine Production
5.8.2 Middle East Sustained-release Medicine Revenue
5.8.3 Key Manufacturers in Middle East
5.8.4 Middle East Sustained-release Medicine Import & Export
5.9 Africa Sustained-release Medicine Market Analysis
5.9.1 Africa Sustained-release Medicine Production
5.9.2 Africa Sustained-release Medicine Revenue
5.9.3 Key Manufacturers in Africa
5.9.4 Africa Sustained-release Medicine Import & Export
5.10 Oceania Sustained-release Medicine Market Analysis
5.10.1 Oceania Sustained-release Medicine Production
5.10.2 Oceania Sustained-release Medicine Revenue
5.10.3 Key Manufacturers in Oceania
5.10.4 Oceania Sustained-release Medicine Import & Export
5.11 South America Sustained-release Medicine Market Analysis
5.11.1 South America Sustained-release Medicine Production
5.11.2 South America Sustained-release Medicine Revenue
5.11.3 Key Manufacturers in South America
5.11.4 South America Sustained-release Medicine Import & Export
6 Sustained-release Medicine Sales Market by Type (2018-2029)
6.1 Global Sustained-release Medicine Historic Market Size by Type (2018-2023)
6.2 Global Sustained-release Medicine Forecasted Market Size by Type (2024-2029)
7 Sustained-release Medicine Consumption Market by Application(2018-2029)
7.1 Global Sustained-release Medicine Historic Market Size by Application (2018-2023)
7.2 Global Sustained-release Medicine Forecasted Market Size by Application (2024-2029)
8 Company Profiles and Key Figures in Sustained-release Medicine Business
8.1 Sanofi
8.1.1 Sanofi Company Profile
8.1.2 Sanofi Sustained-release Medicine Product Specification
8.1.3 Sanofi Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.2 Novartis
8.2.1 Novartis Company Profile
8.2.2 Novartis Sustained-release Medicine Product Specification
8.2.3 Novartis Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.3 Bayer
8.3.1 Bayer Company Profile
8.3.2 Bayer Sustained-release Medicine Product Specification
8.3.3 Bayer Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson Company Profile
8.4.2 Johnson & Johnson Sustained-release Medicine Product Specification
8.4.3 Johnson & Johnson Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.5 Takeda
8.5.1 Takeda Company Profile
8.5.2 Takeda Sustained-release Medicine Product Specification
8.5.3 Takeda Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.6 AstraZeneca
8.6.1 AstraZeneca Company Profile
8.6.2 AstraZeneca Sustained-release Medicine Product Specification
8.6.3 AstraZeneca Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.7 AbbVie
8.7.1 AbbVie Company Profile
8.7.2 AbbVie Sustained-release Medicine Product Specification
8.7.3 AbbVie Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.8 Pfizer
8.8.1 Pfizer Company Profile
8.8.2 Pfizer Sustained-release Medicine Product Specification
8.8.3 Pfizer Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.9 Collegium Pharmaceutical
8.9.1 Collegium Pharmaceutical Company Profile
8.9.2 Collegium Pharmaceutical Sustained-release Medicine Product Specification
8.9.3 Collegium Pharmaceutical Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.10 Inc
8.10.1 Inc Company Profile
8.10.2 Inc Sustained-release Medicine Product Specification
8.10.3 Inc Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.11 Endo Pharmaceuticals
8.11.1 Endo Pharmaceuticals Company Profile
8.11.2 Endo Pharmaceuticals Sustained-release Medicine Product Specification
8.11.3 Endo Pharmaceuticals Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.12 Shanghai Shyndec Pharmaceutical
8.12.1 Shanghai Shyndec Pharmaceutical Company Profile
8.12.2 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Product Specification
8.12.3 Shanghai Shyndec Pharmaceutical Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.13 Zhuhai Rundu Pharmaceutical
8.13.1 Zhuhai Rundu Pharmaceutical Company Profile
8.13.2 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Product Specification
8.13.3 Zhuhai Rundu Pharmaceutical Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.14 China Res Double-Crane
8.14.1 China Res Double-Crane Company Profile
8.14.2 China Res Double-Crane Sustained-release Medicine Product Specification
8.14.3 China Res Double-Crane Sustained-release Medicine Production Capacity, Revenue, Price and Gross Margin (2018-2023)
9 Production and Supply Forecast
9.1 Global Forecasted Production of Sustained-release Medicine (2024-2029)
9.2 Global Forecasted Revenue of Sustained-release Medicine (2024-2029)
9.3 Global Forecasted Price of Sustained-release Medicine (2018-2029)
9.4 Global Forecasted Production of Sustained-release Medicine by Region (2024-2029)
9.4.1 North America Sustained-release Medicine Production, Revenue Forecast (2024-2029)
9.4.2 East Asia Sustained-release Medicine Production, Revenue Forecast (2024-2029)
9.4.3 Europe Sustained-release Medicine Production, Revenue Forecast (2024-2029)
9.4.4 South Asia Sustained-release Medicine Production, Revenue Forecast (2024-2029)
9.4.5 Southeast Asia Sustained-release Medicine Production, Revenue Forecast (2024-2029)
9.4.6 Middle East Sustained-release Medicine Production, Revenue Forecast (2024-2029)
9.4.7 Africa Sustained-release Medicine Production, Revenue Forecast (2024-2029)
9.4.8 Oceania Sustained-release Medicine Production, Revenue Forecast (2024-2029)
9.4.9 South America Sustained-release Medicine Production, Revenue Forecast (2024-2029)
9.4.10 Rest of the World Sustained-release Medicine Production, Revenue Forecast (2024-2029)
9.5 Forecast by Type and by Application (2024-2029)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2024-2029)
9.5.2 Global Forecasted Consumption of Sustained-release Medicine by Application (2024-2029)
10 Consumption and Demand Forecast
10.1 North America Forecasted Consumption of Sustained-release Medicine by Country
10.2 East Asia Market Forecasted Consumption of Sustained-release Medicine by Country
10.3 Europe Market Forecasted Consumption of Sustained-release Medicine by Countriy
10.4 South Asia Forecasted Consumption of Sustained-release Medicine by Country
10.5 Southeast Asia Forecasted Consumption of Sustained-release Medicine by Country
10.6 Middle East Forecasted Consumption of Sustained-release Medicine by Country
10.7 Africa Forecasted Consumption of Sustained-release Medicine by Country
10.8 Oceania Forecasted Consumption of Sustained-release Medicine by Country
10.9 South America Forecasted Consumption of Sustained-release Medicine by Country
10.10 Rest of the world Forecasted Consumption of Sustained-release Medicine by Country
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
12 Market Dynamics
12.1 Market Trends
12.2 Opportunities and Drivers
12.3 Challenges
12.4 Porter's Five Forces Analysis
13 Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer